These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37866082)

  • 1. In silico and in vitro human metabolism of IOX2, a performance-enhancing doping agent.
    Taoussi O; Gameli PS; Berardinelli D; Busardò FP; Tini A; Carlier J
    J Pharm Biomed Anal; 2024 Jan; 238():115759. PubMed ID: 37866082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic studies of hypoxia-inducible factor stabilisers IOX2, IOX3 and IOX4 (in vitro) for doping control.
    Philip M; Mathew B; Karatt TK; Perwad Z; Subhahar MB; Karakka Kal AK
    Drug Test Anal; 2021 Apr; 13(4):794-816. PubMed ID: 33458935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls.
    Thevis M; Milosovich S; Licea-Perez H; Knecht D; Cavalier T; Schänzer W
    Drug Test Anal; 2016 Aug; 8(8):858-63. PubMed ID: 26361079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of liquid chromatography-tandem mass spectrometry-based analytical assays for the determination of HIF stabilizers in preventive doping research.
    Beuck S; Bornatsch W; Lagojda A; Schänzer W; Thevis M
    Drug Test Anal; 2011; 3(11-12):756-70. PubMed ID: 22213684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of 4-hydroxy-
    Carlier J; Malaca S; Huestis MA; Tagliabracci A; Tini A; Busardò FP
    Expert Opin Drug Metab Toxicol; 2022 Dec; 18(12):831-840. PubMed ID: 36609205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of sulfo-conjugated and gluco-conjugated urinary metabolites for detection of methenolone misuse in doping control by LC-HRMS, GC-MS and GC-HRMS.
    Fragkaki AG; Angelis YS; Kiousi P; Georgakopoulos CG; Lyris E
    J Mass Spectrom; 2015 May; 50(5):740-8. PubMed ID: 26259657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the metabolites of the HIF stabilizer FG-4592 (roxadustat) in five different in vitro models and in a human doping control sample using high resolution mass spectrometry.
    Hansson A; Thevis M; Cox H; Miller G; Eichner D; Bondesson U; Hedeland M
    J Pharm Biomed Anal; 2017 Feb; 134():228-236. PubMed ID: 27918992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism Study of Anamorelin, a GHSR1a Receptor Agonist Potentially Misused in Sport, with Human Hepatocytes and LC-HRMS/MS.
    Gameli PS; Taoussi O; Basile G; Carlier J; Busardò FP
    Metabolites; 2023 Aug; 13(8):. PubMed ID: 37623892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection by LC-MS/MS of HIF stabilizer FG-4592 used as a new doping agent: Investigation on a positive case.
    Buisson C; Marchand A; Bailloux I; Lahaussois A; Martin L; Molina A
    J Pharm Biomed Anal; 2016 Mar; 121():181-187. PubMed ID: 26808067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of new exemestane metabolites by liquid chromatography interfaced to electrospray-tandem mass spectrometry.
    de Albuquerque Cavalcanti G; Carius Garrido B; Dias Leal F; Costa Padilha M; Mazzarino M; de la Torre X; Botre F; Radler de Aquino Neto F
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):248-54. PubMed ID: 21924357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lmplementation of the prolyl hydroxylase inhibitor Roxadustat (FG-4592) and its main metabolites into routine doping controls.
    Eichner D; Van Wagoner RM; Brenner M; Chou J; Leigh S; Wright LR; Flippin LA; Martinelli M; Krug O; Schänzer W; Thevis M
    Drug Test Anal; 2017 Nov; 9(11-12):1768-1778. PubMed ID: 28378453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid chromatography-high resolution/ high accuracy (tandem) mass spectrometry-based identification of in vivo generated metabolites of the selective androgen receptor modulator ACP-105 for doping control purposes.
    Thevis M; Thomas A; Piper T; Krug O; Delahaut P; Schänzer W
    Eur J Mass Spectrom (Chichester); 2014; 20(1):73-83. PubMed ID: 24881457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico prediction, LC-HRMS/MS analysis, and targeted/untargeted data-mining workflow for the profiling of phenylfentanyl in vitro metabolites.
    Di Trana A; Brunetti P; Giorgetti R; Marinelli E; Zaami S; Busardò FP; Carlier J
    Talanta; 2021 Dec; 235():122740. PubMed ID: 34517608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of tolvaptan and its metabolites in sports drug testing by high-performance liquid chromatography coupled to tandem mass spectrometry.
    Rzeppa S; Viet LN
    Drug Test Anal; 2016 Oct; 8(10):1090-1094. PubMed ID: 26768215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doping control analysis of trimetazidine and characterization of major metabolites using mass spectrometric approaches.
    Sigmund G; Koch A; Orlovius AK; Guddat S; Thomas A; Schänzer W; Thevis M
    Drug Test Anal; 2014; 6(11-12):1197-205. PubMed ID: 24913825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic study of androsta-1,4,6-triene-3,17-dione in horses using liquid chromatography/high resolution mass spectrometry.
    Kwok WH; Leung GN; Wan TS; Curl P; Schiff PJ
    J Steroid Biochem Mol Biol; 2015 Aug; 152():142-54. PubMed ID: 26031748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing.
    Schänzer W; Guddat S; Thomas A; Opfermann G; Geyer H; Thevis M
    Drug Test Anal; 2013; 5(11-12):810-8. PubMed ID: 23873860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry.
    Wohlfarth A; Roman M; Andersson M; Kugelberg FC; Diao X; Carlier J; Eriksson C; Wu X; Konradsson P; Josefsson M; Huestis MA; Kronstrand R
    Drug Test Anal; 2017 May; 9(5):680-698. PubMed ID: 27448631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications and challenges in using LC-MS/MS assays for quantitative doping analysis.
    Wang Z; Lu J; Zhang Y; Tian Y; Yuan H; Xu Y
    Bioanalysis; 2016 Jun; 8(12):1307-22. PubMed ID: 27241820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.